Ottignies, Belgium

Michael Paul Rene Guillot

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Children's Hospital of Philadelphia. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Paul Rene Guillot. Retrieved from https://idiyas.com/inventor/michael-paul-rene-guillot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Paul Rene Guillot: Innovator in Pharmaceutical Science

Introduction

Michael Paul Rene Guillot is a notable inventor based in Ottignies, Belgium. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on fasoracetam.

Latest Patents

Guillot holds a patent for "Solid forms of fasoracetam." This patent focuses on cocrystals of fasoracetam, including R-fasoracetam, and various coformers. The disclosure includes crystalline materials comprising fasoracetam, as well as pharmaceutical compositions and methods of treatment involving these cocrystals and crystalline materials.

Career Highlights

Guillot is affiliated with The Children's Hospital of Philadelphia, where he applies his expertise in pharmaceutical research. His work has the potential to impact treatment methodologies significantly.

Collaborations

Some of his notable coworkers include Tom Leyssens and Richard Alan Couch, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Michael Paul Rene Guillot's innovative work in pharmaceutical science exemplifies the importance of research and development in creating effective treatments. His contributions through patents and collaborations continue to advance the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…